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Abstract
OBJECTIVE: To observe the influence of Qingrehua-
tan decoction (QRHT) on serum metabolic profile
in young essential hypertension (YEH) patients
with abundant phlegm-heat syndrome and pro-
vide a basis for treatment with the decoction.
METHODS: Twelve male YEH patients were ran-
domly selected and serum samples were collected
for examination before and after 4 weeks of the
treatment with QRHT. Twelve healthy males were
randomly selected and their serum samples were
collected as a control. All serum samples were de-
tected using metabolomic technology with 1H nu-
clear magnetic resonance. Differences in metabo-
lites were studied by principal component analysis
and partial least squares-discriminate analysis,
which produced scores and loadings plots.
RESULTS: After 4 weeks of treatment, serum sub-
stances could be distinguished between the YEH
patients with abundant phlegm-heat syndrome
and the control patients. The specific serum endog-
enous metabolites tended to improve after the
treatment. QRHT can appropriately increase the lev-
els of glucose, lactic acid, citric acid, high-density li-
poprotein, phosphatidylcholine, glycerophosphate
choline, hydroxybutyrate, alanine, and glutamate.
QRHT could also decrease the levels of low-density
lipoprotein/very low-density lipoprotein, lipids,
N-acetyl glycoprotein, and O-acetyl glycoprotein.
CONCLUSION: QRHT can effectively ameliorate
metabolic disorders in YEH Patients with abundant
phlegm- heat syndrome. 1H NMR-based metabolo-
mic technology can provide an objective basis for
the treatment of YEH patients with abundant
phlegm-heat syndrome using QRHT.
© 2015 JTCM. All rights reserved.
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INTRODUCTION
Hypertension is a widely recognized disease that may
cause many common serious diseases, such as coronary
disease and strokes. Approximately 7 million annual
deaths are attributed to hypertension worldwide.1
When classified as an average BP measurement of >
140 mm Hg systolic or > 90 mm Hg diastolic, hyper-
tension occurs in approximately 26% of adults world-
wide. And this is expected to increase to 1.56 billion
people (29%) by 2025.2
Many people in China have turned to Traditional Chi-
nese Medicine (TCM) for antihypertensive treatment.3
Moreover, the efficacy and safety of TCM in the treat-
ment of hypertension has been confirmed by several
clinical studies.4-7
Previous studies have shown that hypertension is a met-
abolic disease.8 Metabolomics is a key technology for
systems biology which uses a holistic approach to bio-
logical and biomedical research, while TCM emphasiz-
es holism and individual treatment and works with the
principle of metabolomics. Therefore, many TCM
studies have used metabolomics to explain mechanisms
of syndrome differentiations and conversion.9-11 Based
on clinical observation, it was found that Qingrehua-
tan decoction (QRHT, the empirical prescription for
clearing heat and dissipating phlegm) has therapeutic
efficacy in treating hypertension. 1H nuclear magnetic
resonance (NMR) metabolomics was used to study the
function and mechanism of QHRT.
MATERIALS ANDMETHODS
Subjects
Twelve male young essential hypertension (YEH) pa-
tients aged 32 to 40 [average: (36 ± 4) years] were se-
lected in the department of Cardiology of Guang'an-
men Hospital from May 2010 to January 2012 and
served as the treatment-naive group before taking
QRHT. They also served as the treatment-experienced
group after taking QRHT for 4 weeks. Twelve healthy
males aged from 30 to 40 [average: (36 ± 4) years]
were included as a control group. All patients gave in-
formed consent and the trial was approved by the Eth-
ics Committee of Guang'anmen Hospital.
Diagnostic criteria
The diagnosis of hypertension followed A Draft of
Chinese Guidelines for Hypertension Prevention and
Treatment (revised edition in 2010).12 Three measure-
ments on separate days (usually at 2-week intervals) of
the blood pressure ≥ 140 and/or ≥ 90 mm Hg, were
sufficient for a diagnosis of hypertension. Grade 1: hy-
pertension was defined as systolic pressure 140-159 mm
Hg and/or diastolic pressure 90-99 mm Hg. Grade
2: hypertension was defined as systolic pressure
160-179 mm Hg and/or diastolic pressure 100-109
mm Hg. Grade 3: hypertension was defined as systolic
pressure ≥ 180 and/or diastolic pressure ≥ 110 mm Hg.
Secondary hypertension was excluded. According to
the latest standards of World Health Organization, can-
didates aged 44 or under were included.13,14
Symptoms of abundant phlegm-heat syndrome in
TCM
The diagnosis of abundant phlegm-heat syndrome fol-
lowed the definition in PRC National Standard for
Clinic Terminology of Traditional Chinese Medical Di-
agnosis and Treatment— Syndromes.15 The main clini-
cal manifestation of abundant phlegm-heat syndrome
includes disturbed mind and Qi movement, cough and
dyspnea, yellow thick sputum, fever and thirst, irritabil-
ity and restlessness, insomnia and dreamful sleep, red
tongue with yellow and greasy fur, rapid or slippery
pulse.
Inclusion criteria
Inclusion criteria were as follows: diagnosis of grade 1
or 2 essential hypertension in accordance with the
guidelines described previously. The diagnosis was con-
ducted by two associate chief TCM physicians. Pa-
tients were included if they were initially diagnosed
with hypertension, had hypertension without regular
administration for years, or had no antihypertensive ad-
ministration in the last 2 weeks. Patients were aged
from 18 to 45 and were informed and consented to
participate in the study.
Exclusion criteria
Exclusion criteria were as follows: patients aged under
18 or over 45 years old; patients with secondary hyper-
tension; patients who regularly use drugs or have used
antihypertensive drugs in the last 2 weeks; patients
with Grade 3 hypertension; patients with blood sugar
or fat abnormalities, hepatic dysfunction, Aminotrans-
ferase (ALT/AST) ≥ 1.5-fold normal value, renal dys-
function, males with creatinine (Cr) > 106 μmol/L, fe-
males with Cr > 97 μmol/L, blood urea nitrogen >
7.1 mmol/L, thyroid function abnormality, hematopoi-
etic function abnormality, or mental diseases; patients
with allergic physique and/or allergies to many drugs;
patients participating in other clinical trials in the last
month; patients unwilling to participate in this clinical
trial; patients failing to take medication regularly or
with incomplete data.
Reagents and instruments
Chemicals used included: 99.8% deuterium oxide
(D2O), batch number: 20111112 (Cambridge Isotope
Laboratories Inc. Corporation, Andover, MA, USA);
and 3-(trimethylsilyl) propionic-2,2,3,3-D4 acid sodi-
um salt (TSP-deuterated), batch number: 1668-E
(Merck Corporation, Montreal, Canada). Instruments
included: refrigerated centrifuge (Beckman, Pasadena,
CA, USA); standard pipettes 100-1000 μL (GILSON
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Incorporated, Villiers Le Bel, France); standard pi-
pettes 1-20 μL (Eppendorf-MiniSpin/plus, Hamburg,
German); Value plus ultra low temperature refrigerator
(Thermo Revco, Waltham, MA, USA); Centrifuge
5415D high-speed refrigerated centrifuge (Eppen-
dorf-MiniSpin/plus, Hamburg, German); Bruker
AVANCE III 500 MHz nuclear magnetic resonance
spectrometer (Bruker Corporation, Zürich, Switzer-
land). Main configuration: field intensity of the super-
conducting magnet was 11.75 T (500 MHz); 1H/13C/
31P/19F 4N probe, gradient reversed-phase probe
(109Ag-31P)/high-resolution magic angle spinning
probe (15N-31P).
QRHT decoction preparation
QRHT decoction included following contents: Huan-
glian (Rhizoma Coptidis) 9 g, Wuzhuyu (Fructus Evodi-
ae Rutaecarpae) 6 g, Sangbaipi (Cortex Mori Albae Radi-
cis) 30 g, Digupi (Cortex Lycii Radicis) 30 g, Mudanpi
(Cortex Moutan Radicis) 10 g, Xiakucao (Spica Prunel-
lae Vulgaris) 30 g, Banxia (Rhizoma Pinelliae) 9 g, Bai-
zhu (Rhizoma Atractylodis Macrocephalae) 12 g, Zexie
(Rhizoma Alsmatis) 30 g, and Fuling (Poria) 30 g. The
herbs were boiled in water, and the decoction was tak-
en twice a day for 4 weeks. Drugs that may influence
blood pressure were suspended during the treatment.
Method of serum pretreatment
A total of 2 mL of fasting blood were collected in Vacu-
ette disposable plain tube, mixed with EDTA anticoag-
ulant in the morning, set for 2 h at room temperature,
and centrifuged at 3000 r/min for 15 min at 4 ℃ to
isolate serum. All serum samples were kept at ﹣80 ℃
until use. After thawing at room temperature, 20 μL
of supernatant was blended with 40 μL of 0.05% TSP
with D2O and H2O in a ratio of 1∶9. The prepared se-
rum samples in the 1.7 mm tube were tested in the
NMR spectrometer.
Data acquisition and processing
Nuclear Overhauser effect spectroscopy (NOESY),
Carr-Purcell-Meiboom-Gill (CPMG), and longitudi-
nal eddy-current delay (LED) were performed on a
pre-saturated Fourier variable NMR spectrometer. The
parameters of the experiment were as follows: spectrum
width of 8000 Hz, pre-saturation time of 2 seconds,
sampling number of 32k, accumulation number of
128, and the frequencies of pre-saturation and center
were all at the position of the water peak. Free induc-
tion decay (FID) signals were transferred via 32 k Fou-
rier transformation to gain a one-dimensional NMR
spectrogram. TSP was the chemical migration refer-
ence peak at 0 ppm, and using MIXtures software v.
3.0 (AMIX) (Bruker Biospin, Faellanden, Switzerland),
the segmental integral calculus (0.04 ppm per seg-
ment) was performed from 0.5-6 ppm. After normal-
ization, the data were saved in an excel file or text file
for pattern recognition analysis.
Statistical analysis
The data were analyzed and the scores plot and load-
ings plot were obtained by orthogonal partial least
squares discriminant analysis (OPLS-DA). The data
were first analyzed by pattern recognition of principal
component analysis (PCA) in SIMCA-P12.0 (Umet-
rics, Umeå, Sweden) conducted with orthogonal signal
correction if necessary, and analyzed by partial least
squares regression discriminant analysis. These meth-
ods are in accordance with previous studies.16,17 The R2
describes how well the data fit with the derived model,
whereas Q2 describes the predictive ability of the de-
rived model and provides a measure of the model quali-
ty with Q2 > 0.5 considered as 'good' and Q2> 0.9 con-
sidered as 'excellent'.
RESULTS
1H NMR spectra of serum samples
A typical 500 MHz 1H NMR spectra of serum from a
YEH patient with abundant phlegm-heat syndrome be-
fore and after taking QRHT and one control are
shown in Figures 1 and 2. Differences in these three
spectra in small molecular substances and macromolec-
ular substances can be roughly observed.
Segmental integral value of 1H NMR CPMG spectra
The segmental integral value of the 1H NMR CPMG
spectrum was analyzed with PCA. Differences among
treatment-naive, treatment-experienced, and healthy
control patients could be obviously distinguished. The
scores of the treatment-experienced group were be-
tween the treatment-naive group and the healthy con-
trol (Figure 3). The scores of the three groups possibly
indicated that QRHT could effectively ameliorate
small metabolite disorders in the serum of YEH pa-
tients with abundant phlegm-heat syndrome (Figure 3).
The main differences in metabolites among the three
groups were: lactate (1.34), low-density lipoprotein
(LDL)/very low-density lipoprotein (VLDL) (0.90/
1.30), high-density lipoprotein (HDL) (0.86/1.26), un-
saturated fatty acid (5.30), phosphorylcholine/phospha-
tidylcholine (3.22), choline/phosphocholine (3.20),
glucose (3.42/3.70), N-acetyl glycoprotein (2.04), and
O-acetyl glycoprotein (2.06) (Figure 4).
Segmental integral value of 1H NMR LED spectra
The segmental integral value of the 1H NMR LED
spectra was analyzed with PLS-DA. Differences among
the treatment-naive, treatment-experienced, and
healthy control groups were obviously distinguishable.
The scores of the treatment-experienced group were be-
tween the treatment-naive group and the healthy con-
trol group, which indicates that QRHT may be effec-
tive for treating hypertension (Figure 5).
The main differences in metabolites among the three
groups were: lactate (1.34), LDL/VLDL (0.90/1.30),
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HDL (0.82/0.86/1.22/1.26), unsaturated fatty acid
(5.3), lipids (2.02), and phosphorylcholine/phosphati-
dylcholine (3.22) (Figure 6).
Different metabolites in serum of YEH patients with
abundant phlegm-heat syndrome
The loadings plots of the treatment group were ob-
tained (Figures 4, 6) and indicate that the main differ-
ences in metabolites among the three groups are: lac-
tate (1.34), LDL/VLDL (0.90/1.30), HDL (0.82/0.86/
1.22/1.26), unsaturated fatty acid (5.30), lipids (2.02),
phosphorylcholine/phosphatidylcholine (3.22), cho-
line/phosphocholine (3.20), glucose (3.42/3.70),
N-acetyl glycoprotein (2.04), and O-acetyl glycopro-
tein (2.06). These changes indicate that QRHT may
ameliorate altered metabolites after treatment for 4
weeks (Table 1).
DISCUSSION
Hypertension can be exacerbated by improper diet,
work stress, excessive anxiety, smoking, and drinking.
According to TCM theory, pathogenic factors, such as
phlegm-dampness and heat, invade easily under stress.
Pathogenic factors will linger in blood, vessels, or gaps
between muscles. Internal and external dampness accu-
mulates and leads to abundant phlegm-heat. Ancient
Chinese physicians recorded the pathogenesis of hyper-
tension, such as "No phlegm no vertigo,"18 and "Head-
ache is always caused by phlegm, and fire can make it
even worse."19 Pathogenic factors like wind, phlegm,
heat, and deficiency are all important to the occurrence
of hypertension. The phlegm invades the body, not on-
ly inducing Yang deficiency of both spleen and kidney,
but also causing liver wind stirring, which produces
blood stagnation in vessels and leads to hypertension.
Therefore, attention should be paid to phlegm when
treating hypertension. Gong, 20 a TCM physician in the
Ming Dynasty, mentioned that fire is the core of
phlegm, while phlegm is the manifestation of fire. Zhu 21
also hypothesized that treatments of fire should be em-
phasized when the fire causes phlegm. TCM physicians
have characterized the relationship between fire and
phlegm and emphasized the importance of clearing
heat in the treatment of hypertension.
Based on TCM theory and clinical experience, we have
developed QRHT to treat hypertension. In the pre-
scription, the bitter cold drug Huanglian (Rhizoma
Coptidis) and the bitter pungent cold drug Mudanpi
(Cortex Moutan Radicis) are the sovereign drugs that fo-
cus on clearing away the heat in the triple energizer.
Furthermore, Huanglian (Rhizoma Coptidis) can elimi-
nate dampness and Mudanpi (Cortex Moutan Radicis)
can cool the blood and dissipate blood stasis. When
αGlc βGlc
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Lac
TMAO/Betaine
Creatine Citrate
Lac
Ile/Leu
Cho/Pcho Met Ace Ala
Glucose & amino acid
Glutamine N-Ac
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Figure 1 Typical 500 MHz 1H-NMR Carr-Purcell-Meiboom-Gill spectra of serum from a young essential hypertension patient with
abundant phlegm-heat syndrome after taking QRHT
A: treatment-naive; B: treatment-experienced; C: healthy Control. Ile: isoleucine; Leu: leucine; Val: valine; Lac: lactic acid; Ala: ala-
nine; N-Ac: N-Acetyl glycoproteins; Met: methionine; Ace: acetate; Gln: glutamine; Cho: choline; Glc: glucose; TMAO: trimethyl-
amine-N-oxide. 1H-NMR: 1H nuclear magnetic resonance; QRHT: Qingrehuatan decoction.
f1 (ppm)
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the dampness is removed, the phlegm will also be elimi-
nated. The tasteless cold drug Digupi (Cortex Lycii
Radicis) can purge the torpid fire, the sweet cold drug
Sangbaipi (Cortex Mori Albae Radicis) can clear lung
heat, the bitter pungent cold drug Xiakucao (Spica
Prunellae Vulgaris) can purge the ministerial fire, and
the sweet cold drug Zexie (Rhizoma Alsmatis) can clear
heat in the kidney and bladder. These four herbs assist
the sovereign drugs in clearing heat. The sweet tasteless
neutral drug Fuling (Poria) can drain dampness, espe-
cially in the spleen, and promote urination. Zexie (Rhi-
zoma Alsmatis) and Digupi (Cortex Lycii Radicis) are al-
so good at draining dampness and promoting urina-
tion, especially the turbidity in kidney. Finally, Sangbai-
pi (Cortex Mori Albae Radicis) can promote urination
by purging the lung. These four herbs help the sover-
PtdCho Lipid-CH2CH2CO-
VLDL / LDL-(CH2)n
Lipid-CH2CO-
VLDL / LDL-(CH2)n
Lipid-CH = CH- Lipid=CHCH2CH-
N-Ac
HDL-CH3
A
B
C
6.0 5.8 5.6 5.4 5.2 5.0 4.8 4.6 4.4 4.2 4.0 3.8 3.6 3.4 3.2 3.0 2.8 2.6 2.4 2.2 2.0 1.8 1.6 1.4 1.2 1.0 0.8 0.6 0.4 0.2 0.0
Figure 2 Typical 500 MHz 1H NMR longitudinal eddy-delay spectra of serum from a young essential hypertension patient with
abundant phlegm-heat syndrome after taking QRHT
A: treatment-naive; B: treatment-experienced; C: healthy control. N-Ac: N-Acetyl glycoproteins; VLDL: very low-density lipopro-
tein; LDL: low-density lipoprotein; HDL: high density lipoprotein; ptdcho: phosphatidylcholine; 1H NMR: 1H nuclear magnetic reso-
nance; QRHT: Qingrehuatan decoction.
f1 (ppm)
Figure 3 1H NMR Carr-Purcell-Meiboom-Gill principal component analysis plot (t[1] vs t[2]) of the treatment-experienced group of
young essential hypertension patients with abundant phlegm-heat syndrome
Healthy control group: healthy males aged from 30 to 40; treatment-naive group: young essential hypertension patients without
any treatment; treatment-experienced group: those patients taking the Qingrehuatan decoction for 4 weeks, R2X = 0.916, Q2 =
0.72). 1H NMR: 1H nuclear magnetic resonance.
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eign drugs with relieving the phlegm and the dampness
by invigorating the lung, the spleen, and the kidney to
regulate water passage. Xiakucao (Spica Prunellae Vul-
garis) can also relieve stagnation and resolve hard
masses, and Fuling (Poria) can tranquillize the mind.
These two herbs are included for emotional regula-
tion. Therefore, there are five minister drugs in the
decoction. The character and taste of all the herbs is
bitter and cold, which can curb the stagnated fire
from being eliminated. The pungent hot drug Wu-
zhuyu (Fructus Evodiae Rutaecarpae), the pungent
warm drug Banxia (Rhizoma Pinelliae), and the sweet
warm drug Baizhu (Rhizoma Atractylodis Macrocepha-
lae) were added to the prescription to reduce harm
to the stomach from coldness.
The levels of glucose, lactic acid, and citric acid in-
creased after taking QRHT for 4 weeks. Though the re-
lationship between clearing heat and dissipating
phlegm and the levels of blood glucose have not been
studied, QRHT could effectively improve glucose me-
tabolism in this study. Therefore, invigorating the
spleen and eliminating phlegm could improve digestive
function and assimilation, and clearing heat precludes
the constitution of excessive Yang.
The levels of LDL/VLDL, lipids, and unsaturated fatty
acid decreased and the concentration of HDL, phos-
phorylcholine/phosphatidylcholine, choline/phospho-
choline, glycerophosphorylcholine and 3-hydroxybutyr-
ate increased after 4 weeks of treatment with QRHT.
Chang et al 22 found similar results in their experiment.
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Figure 4 1H NMR Carr-Purcell-Meiboom-Gill principal component analysis loadings plot (p[1] vs p[2]) of the treatment-experi-
enced group of young essential hypertension patients with abundant phlegm-heat syndrome
1H-NMR: 1H nuclear magnetic resonance.
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Figure 5 1H NMR longitudinal eddy current delay principal component analysis plot (t[1] vs t[2]) of the treatment-experienced
group of young essential hypertension patients with abundant phlegm-heat syndrome
Healthy control group: healthy males aged from 30 to 40; treatment-naive group: young essential hypertension patients without
any treatment; treatment-experienced group: those patients taking the Qingrehuatan decoction for 4 weeks, R2X=0.996, Q2=
0.943). 1H-NMR: 1H nuclear magnetic resonance.
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Phlegm is produced by foods and drinks like other nor-
mal fluids. However, if the fluids turn into essentials,
then they will improve the body. Otherwise, the fluids
form phlegm and harm the body. It is hypothesized
that QRHT helps eliminate phlegm and produce essen-
tials like Qi and blood.
The increased in alanine and glutamate and the de-
crease in N-acetyl glycoprotein and O-acetyl glycopro-
tein after 4 weeks of treatment with QRHT possibly in-
dicate that the blood stasis was partly treated, and that
Yang could reach the upper orifices so that blood pres-
sure could decrease. After treatment, the abnormal met-
abolic symptoms of hypertensive patients were re-
solved. Therefore, QRHT can not only reduce blood
pressure, but also improve the metabolic disorder of
patients.
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